Trials / Conditions / Neuroendocrine Carcinoma Metastatic
Neuroendocrine Carcinoma Metastatic
4 registered clinical trials studyying Neuroendocrine Carcinoma Metastatic — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | FTT PET/CT in Pancreatic Neuroendocrine Tumors NCT07114939 | Abramson Cancer Center at Penn Medicine | Phase 1 |
| Unknown | Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms NCT05709171 | Rigshospitalet, Denmark | Phase 2 |
| Enrolling By Invitation | Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients NCT05396118 | Rigshospitalet, Denmark | Phase 2 |
| Withdrawn | Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Prima NCT04276597 | Excel Diagnostics and Nuclear Oncology Center | Phase 2 |